Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas

Autor: Gil, J, Marques-Pamies, M, Jorda, M, Fajardo-Montanana, C, Garcia-Martinez, A, Sampedro, M, Serra, G, Salinas, I, Blanco, A, Valassi, E, Sesmilo, G, Carrato, C, Camara, R, Lamas, C, Casano-Sancho, P, Alvarez, CV, Bernabeu, I, Webb, SM, Pico, A, Marazuela, M, Puig-Domingo, M, Santos, A, Vida-Pardo, J.I.

Publikováno v: CLINICAL ENDOCRINOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Objective Large somatotrophic adenomas depict poor response to somatostatin receptor ligands (SRLs). Debulking has shown to enhance SRLs effect in some but not all cases and tumour volume reduction has been proposed as the main predictor of response.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::dc48d52bd21ed865f1b3fac42b40f04e
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4897

Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH producing adenomas

Autor: Gil, J, Marques-Pamies, M, Jorda, M, Fajardo-Montanana, C, Garcia-Martinez, A, Sampedro, M, Serra, G, Salinas, I, Blanco, A, Valassi, E, Sesmilo, G, Carrato, C, Camara, R, Lamas, C, Casano-Sancho, P, Alvarez, CV, Bernabeu, I, Webb, SM, Pico, A, Marazuela, M, Puig-Domingo, M

Publikováno v: CLINICAL ENDOCRINOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Clinical Endocrinology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

Objective Large somatotrophic adenomas depict poor response to somatostatin receptor ligands (SRLs). Debulking has shown to enhance SRLs effect in some but not all cases and tumour volume reduction has been proposed as the main predictor of response.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::78290a41c6b5700031c4be82e33f079f
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13295

Monitorización del tratamiento con tiroxina en el hipotiroidismo primario y central

Autor: Sesmilo, G.

Publikováno v: In Endocrinologia y Nutricion 2005 52(7):358-364

Prevalence of acromegaly in patients with symptoms of sleep apnea

Autor: Sesmilo G, Resmini E, Sambo M, Blanco C, Calvo F, Pazos F, Fernández-Catalina P, Martínez de Icaya P, Páramo C, Fajardo C, Marazuela M, Álvarez-Escolá C, Díez JJ, Perea V, ACROSAHS study group

Publikováno v: PLoS One
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

Acromegaly is a rare disease with nonspecific symptoms with acral enlargement being almost universally present at diagnosis. The estimated prevalence is 40-125 cases/million but targeted universal screening studies have found a higher prevalence (abo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::8f05d3b16d34b575d50e0e0d81265db4
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3386